Neuren Pharmaceutical's partner Acadia reports boosted sales of the Rett syndrome drug Daybue, but Neuren notes two-thirds of ...

People with a wheat or soy allergy could experience a "serious or life-threatening" reaction if they consume the product.

Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and ...

MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Orthofix Medical’s 2025 sell-off presents a value opportunity, says Rewey Asset Management. Learn why insiders are buying and ...

Baker Mayfield addressed the NFL’s 2025 smelling salts ban with sarcasm and hinted at a surprising new game day energy boost.

A new health warning from Florida officials this week is renewing debate over raw, unpasteurized milk and the controversial political movement growing behind it.

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

A Rankin County teenager’s life-changing medication is being denied approval by the U.S. Food and Drug Administration, leaving him and many others with rare diseases unsure of their futures.

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

Jazz Pharmaceuticals bet $1 billion on the commercial potential of a first-in-class oral imipridone for recurrent H3 K27M-mutant diffuse glioma.